Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,023 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Mailankody S, Matous JV, Chhabra S, Liedtke M, Sidana S, Oluwole OO, Malik S, Nath R, Anwer F, Cruz JC, Htut M, Karski EE, Lovelace W, Dillon M, Butz E, Ying W, Balakumaran A, Kumar SK. Mailankody S, et al. Among authors: nath r. Nat Med. 2023 Feb;29(2):422-429. doi: 10.1038/s41591-022-02182-7. Epub 2023 Jan 23. Nat Med. 2023. PMID: 36690811 Clinical Trial.
Publisher Correction: Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Mailankody S, Matous JV, Chhabra S, Liedtke M, Sidana S, Oluwole OO, Malik S, Nath R, Anwer F, Cruz JC, Htut M, Karski EE, Lovelace W, Dillon M, Butz E, Ying W, Balakumaran A, Kumar SK. Mailankody S, et al. Among authors: nath r. Nat Med. 2023 Dec;29(12):3271. doi: 10.1038/s41591-023-02306-7. Nat Med. 2023. PMID: 36932247 No abstract available.
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Siddiqi T, Maloney DG, Kenderian SS, Brander DM, Dorritie K, Soumerai J, Riedell PA, Shah NN, Nath R, Fakhri B, Stephens DM, Ma S, Feldman T, Solomon SR, Schuster SJ, Perna SK, Tuazon SA, Ou SS, Papp E, Peiser L, Chen Y, Wierda WG. Siddiqi T, et al. Among authors: nath r. Lancet. 2023 Aug 19;402(10402):641-654. doi: 10.1016/S0140-6736(23)01052-8. Epub 2023 Jun 6. Lancet. 2023. PMID: 37295445 Clinical Trial.
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Ariza-Heredia EJ, Winston DJ, Rowley SD, Mullane K, Chandrasekar P, Hari P, Avery RK, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, El Haddad L, Shah DP, Jiang Y, Khawaja F, Dadwal S, Blanchard T, Chemaly RF. Ariza-Heredia EJ, et al. Among authors: nath r. Open Forum Infect Dis. 2023 Jul 22;10(8):ofad386. doi: 10.1093/ofid/ofad386. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37636519 Free PMC article.
Awareness of HPV vaccine and its socio-demographic determinants among the parents of eligible daughters in Bangladesh: A nationwide study.
Eva FN, Khan MAS, Islam T, Monisha UK, Meem NE, Hossain MA, Goutam A, Zerin T, Alam N, Nath R, Sifat S, Sultana S, Sultana MS, Saha SK, Sarker NE, Rahman ML, Nabi MH, Hawlader MDH. Eva FN, et al. Among authors: nath r. Heliyon. 2024 May 8;10(10):e30897. doi: 10.1016/j.heliyon.2024.e30897. eCollection 2024 May 30. Heliyon. 2024. PMID: 38778954 Free PMC article.
Emerging concern of nano-pollution in agro-ecosystem: Flip side of nanotechnology.
Moulick D, Majumdar A, Choudhury A, Das A, Chowardhara B, Pattnaik BK, Dash GK, Murmu K, Bhutia KL, Upadhyay MK, Yadav P, Dubey PK, Nath R, Murmu S, Jana S, Sarkar S, Garai S, Ghosh D, Mondal M, Chandra Santra S, Choudhury S, Brahmachari K, Hossain A. Moulick D, et al. Among authors: nath r. Plant Physiol Biochem. 2024 Jun;211:108704. doi: 10.1016/j.plaphy.2024.108704. Epub 2024 May 3. Plant Physiol Biochem. 2024. PMID: 38728836 Review.
1,023 results